Adalimumab
Biologic injection for arthritis, IBD and psoriasis.
- Starts working
- Varies
- Half-life
- About 2 weeks
- In use since
- 2002
- Pregnancy
- Use with caution
Overview
Adalimumab blocks TNF, a central driver of inflammation. Self-injected every 1–2 weeks, it treats rheumatoid arthritis, ankylosing spondylitis, Crohn's, ulcerative colitis, psoriasis and hidradenitis. As Humira it was the world's top-selling drug for years; cheaper biosimilars are now widely available.
How it works
Mops up a key inflammation signal.
Adalimumab belongs to the TNF inhibitors. How TNF inhibitors work: mop up TNF, a key inflammation messenger. Infections like TB can reactivate, so people are screened first.
Uses
- Rheumatoid and psoriatic arthritis
- Ankylosing spondylitis
- Crohn's disease and ulcerative colitis
- Psoriasis
- Hidradenitis suppurativa
- Uveitis
Available as: pre-filled pen, pre-filled syringe.
Typical dose
- Adults
- 40 mg under the skin every other week (some conditions start higher or go weekly).
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Injection-site reactions
- Upper respiratory infections
- Headache
Serious — get medical help
Uncommon, but need prompt attention
- Serious infections including TB reactivation
- Lymphoma (rare)
- Demyelination
- Heart failure worsening
Warnings
- TB and hepatitis B screening first
- No live vaccines
- Pause during serious infection
Interactions
- Other biologics — avoid combining
- Live vaccines
Pregnancy and breastfeeding
Use with caution
Often continued into pregnancy for IBD; baby's live vaccines may be delayed.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Humira, Hadlima, Hyrimoz, Yuflyma
- United Kingdom
- Humira, Amgevita, Imraldi, Yuflyma
- India
- Exemptia, Adfrar
- Australia
- Humira, Amgevita
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
History
India launched the world's first adalimumab biosimilar, Exemptia, in 2014.
Common questions
Are biosimilars as good?
Yes — they're tested to show no meaningful difference in effect or safety.
Do I need a prescription for Adalimumab?
Yes — Adalimumab is prescription-only in most countries.
Can I take Adalimumab during pregnancy?
Use with caution. Often continued into pregnancy for IBD; baby's live vaccines may be delayed. Always check with a doctor or midwife.
Related medicines
Infliximab
IV anti-TNF biologic for Crohn's and arthritis.
RxTNF inhibitorsMethotrexate
Once-weekly anchor drug for rheumatoid arthritis.
RxWHOConventional DMARDsSecukinumab
Biologic for psoriasis and spondyloarthritis.
RxInterleukin inhibitorsEtanercept
Soluble TNF receptor injection for arthritis and psoriasis.
RxWHOTNF inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L04AB04
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.